Murine tyrosinase expressed by a T7 vector in bone marrow-derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice

Cancer Gene Therapy

Volumn 7, Issue 11, 2000, Pages 1448-1455

  Li, Jinhua ^a   Holmes, Lillia M ^a   Franek, Karl J ^b   Wagner, Thomas E ^a,b   Wei, Yanzhang ^a,b  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

Dendritic cells; Gene transfer; Immunotherapy; Melanoma; T7 system; Tryrosinase

Indexed keywords

COMPLEMENTARY DNA; MONOPHENOL MONOOXYGENASE; PLASMID VECTOR; RECOMBINANT INTERLEUKIN 2; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIOPHAGE T7; CANCER CELL DESTRUCTION; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; DNA SEQUENCE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE EXPRESSION SYSTEM; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GROWTH INHIBITION; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALIA; MURINAE;

EID: 0033673413     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700260     Document Type: Article

References (27)

1. The dendritic cell system and its role in immunogenicity
2. Primary stimulation by dendritic cells induces antiviral proliferation and cytotoxic T-cell responses in vitro
3. + CTLs from naive precursors
4. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
5. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
6. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptide elicit protective and therapeutic antitumor immunity
7. Dendritic cells as adjuvants for class I major histocompatibility complex restricted antitumor immunity
8. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
9. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
10. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
11. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
12. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T-cell activation
13. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or 'self' antigens induce antitumor immunity in vivo
14. Induction of protective antitumor immunity by gene-modified dendritic cells
15. Economou JS genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells
16. High-efficiency adenovirus-mediated gene transfer to human dendritic cells
17. Retroviral transduction of human dendritic cells with tumor-associated antigen gene
18. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: Induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo
19. Enhanced transgene expression and effective in vivo antitumor immune responses initiated by dendritic progenitors transfected with a nonviral T7 vector expressing a model tumor antigen
20. A self-initiating eukaryotic transient gene expression system based on cotransfection of bacteriophage T7 RNA polymerase and DNA vector containing a T7 autogene
21. Product review. New mammalian expression vectors
22. Emerging concepts in cancer vaccine development
23. Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene
24. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: Implications for immunotherapy
25. + T lymphocytes
26. Subcellular trafficking of the cytoplasmic expression system